Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation
David Castel(Inserm), Marie‐Anne Debily(Inserm), Chris Jones(North Carolina State University), Stefan M. Pfister(Heidelberg University), Kévin Beccaria(Hôpital Necker-Enfants Malades), Arnault Tauziède‐Espariat(Centre Hospitalier Sainte-Anne), Nathalie Boddaert(St Nicholas Hospital), Jacques Grill(Institut Gustave Roussy), Samia Ghermaoui(Inserm), Thomas Kergrohen(Inserm), Alan Mackay(Institute of Cancer Research), Pascale Varlet(Inserm), David Jones(German Cancer Research Center), Emmanuèle Lechapt(Université Paris Cité), Christof M. Kramm(Universitätsmedizin Göttingen), Stéphanie Puget(St Nicholas Hospital), Thomas Blauwblomme(Délégation Paris 5)
Cited by 195
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
|Cancer Cell|2017|1.3k
The whole-genome landscape of medulloblastoma subtypes
|Nature|2017|1.2k